TRIPTODUR Resources & Support

Here you'll find helpful information and resources to help support you and your patients' Triptodur needs, including:

  • - Triptodur Care Program
  • - Triptodur Care Copay Savings Program
  • - How to Prescribe
  • - Triptodur Reconstitution and Administration Resources

TRIPTODUR Care Program

Obstacles may arise when starting a treatment; rest assured Triptodur cares.

Comprehensive support through the Triptodur Care Program includes:

  • Benefit investigations for pharmacy and medical claims
  • Prior authorization and appeal support
  • Copay savings program for eligible patients*
  • Dedicated care team for streamlined support to both parents and healthcare providers
  • Support Team available from 8AM to 8PM (ET)
  • Initiate, enroll and track your referrals at TriptodurCare.com

TRIPTODUR Care Copay Savings Program

is available for eligible patients.*

Visit www.TriptodurCare.com or call 833-401-CARE to activate your Savings Program.

*Please review Terms and Conditions below. For eligible patients only. Not valid for patients covered under Medicaid, Medicare or other government insurance program or if prohibited by law.

Triptodur Care Program: Prescribe with Confidence

Triptodur can be filled through network specialty pharmacy.

Here are 4 different ways to prescribe:

eRx

Submit a prescription for Triptodur via eRx and select:

ASPN Pharmacies, LLC, Florham Park, NJ 07932

NPI: 1538590690

Phone

Contact Triptodur Care Program to submit a prescription over the phone.


Call (833) 401-CARE or
(973) 437-2390,
Monday – Friday, 8:00AM-8:00PM ET

Prescriber Portal

Go to
www.TriptodurCare.com
to access the Prescriber
Portal to submit a prescription.

Fax

Download the Patient Enrollment Prescription
Form below or from
www.TriptodurCare.com

Fax to (877) 650-7041

Triptodur can also be purchased direct via Specialty Distributors. For more information, or assistance on medical claims, call the
Triptodur Care Program at
(833) 401-CARE
or (973) 437-2390, Monday – Friday, 8:00AM-8:00PM ET

Important Administration Information

The following Administration Booklet and
step-by-step video contain important instructions for the reconstitution and administration of Triptodur prior to injection.

Watch Triptodur
Administration Video

Terms and Conditions

By using the Triptodur Savings Coupon, you certify that you currently meet the eligibility criteria and will comply with the Terms and Conditions described below:

- Savings Coupon is not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare, or other federal or state healthcare programs (including any state prescription drug assistance programs and the Government Health Insurance Plan available in Puerto Rico [formerly known as “La Reforma De Salud”]), or if prohibited by law.

- Savings Coupons are not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs that reimburse you for the entire cost of your prescription drugs.

- Insured must be 18 years of age or older; patients must be 2 years of age or older.

- Each patient is limited to one active Savings Coupon at a time during this offering period and the Savings Coupons are not transferable.

- Savings Coupon may be used once every 180 days. Maximum savings of $6,000 per year. Up to $6,000 off of your out-of-pocket cost on the 1st fill and the remaining balance off the out-of-pocket cost on the 2nd fill.

- The Savings Coupon cannot be combined with any other rebate or coupon, free trial, or similar offer for the specified prescription.

- The Savings Coupon will be accepted at in-network participating pharmacies and providers.

- This Savings Coupon is not health insurance.

- This offer is good only in the United States and Puerto Rico.

- Arbor reserves the right to rescind, revoke, or amend the Savings Coupon without notice.

- Offer valid from 8/6/18 to 12/31/20. No membership fees apply.

IMPORTANT SAFETY INFORMATION FOR TRIPTODUR

INDICATION

TRIPTODUR is indicated for the treatment of pediatric patients 2 years of age and older with central precocious puberty (CPP).

IMPORTANT SAFETY INFORMATION

Contraindications

TRIPTODUR is contraindicated in:

  • Individuals with a known hypersensitivity to triptorelin or any other component of the product, or other GnRH agonists or GnRH.
  • Women who are or may become pregnant. Expected hormonal changes that occur with TRIPTODUR treatment increase the risk for pregnancy loss and fetal harm when administered to a pregnant woman. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be advised of the potential risk to the fetus.

Warnings and Precautions

Initial Rise of Gonadotropins and Sex Steroid Levels - During the early phase of therapy, gonadotropins and sex steroids rise above baseline because of the initial stimulatory effect of the drug. Therefore, a transient increase in clinical signs and symptoms of puberty, including vaginal bleeding, may be observed during the first weeks of therapy or after subsequent doses.

Psychiatric Events - Psychiatric events have been reported in patients taking GnRH agonists. Postmarketing reports with this class of drugs include symptoms of emotional lability, such as crying, irritability, impatience, anger, and aggression. Monitor for development or worsening of psychiatric symptoms during treatment with TRIPTODUR.

Convulsions - Postmarketing reports of convulsions have been observed in patients receiving GnRH agonists, including triptorelin. These included patients with a history of seizures, epilepsy, cerebrovascular disorders, central nervous system anomalies or tumors, and patients on concomitant medications that have been associated with convulsions such as bupropion and SSRIs. Convulsions have also been reported in patients in the absence of any of the conditions mentioned above.

Adverse Reactions

In clinical trials for TRIPTODUR, the most common adverse reactions (≥4.5%) are injection site reactions, menstrual (vaginal) bleeding, hot flush, headache, cough, and infections (bronchitis, gastroenteritis, influenza, nasopharyngitis, otitis externa, pharyngitis, sinusitis, and upper respiratory tract infection).

You are encouraged to report side effects of prescription drugs to Arbor Pharmaceuticals, LLC Medical Information at 1-866-516-4950 or to the FDA at www.fda.gov/medwatch or call 1-800-FDA-1088.

For additional safety information, please consult the TRIPTODUR full Prescribing Information

References

IMPORTANT SAFETY INFORMATION FOR TRIPTODUR

INDICATION

TRIPTODUR is indicated for the treatment of pediatric patients 2 years of age and older with central precocious puberty (CPP).

IMPORTANT SAFETY INFORMATION

Contraindications

TRIPTODUR is contraindicated in:

  • Individuals with a known hypersensitivity to triptorelin or any other component of the product, or other GnRH agonists or GnRH.
  • Women who are or may become pregnant. Expected hormonal changes that occur with TRIPTODUR treatment increase the risk for pregnancy loss and fetal harm when administered to a pregnant woman. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be advised of the potential risk to the fetus.

Warnings and Precautions

Initial Rise of Gonadotropins and Sex Steroid Levels - During the early phase of therapy, gonadotropins and sex steroids rise above baseline because of the initial stimulatory effect of the drug. Therefore, a transient increase in clinical signs and symptoms of puberty, including vaginal bleeding, may be observed during the first weeks of therapy or after subsequent doses.

Psychiatric Events - Psychiatric events have been reported in patients taking GnRH agonists. Postmarketing reports with this class of drugs include symptoms of emotional lability, such as crying, irritability, impatience, anger, and aggression. Monitor for development or worsening of psychiatric symptoms during treatment with TRIPTODUR.

Convulsions - Postmarketing reports of convulsions have been observed in patients receiving GnRH agonists, including triptorelin. These included patients with a history of seizures, epilepsy, cerebrovascular disorders, central nervous system anomalies or tumors, and patients on concomitant medications that have been associated with convulsions such as bupropion and SSRIs. Convulsions have also been reported in patients in the absence of any of the conditions mentioned above.

Adverse Reactions

In clinical trials for TRIPTODUR, the most common adverse reactions (≥4.5%) are injection site reactions, menstrual (vaginal) bleeding, hot flush, headache, cough, and infections (bronchitis, gastroenteritis, influenza, nasopharyngitis, otitis externa, pharyngitis, sinusitis, and upper respiratory tract infection).

You are encouraged to report side effects of prescription drugs to Arbor Pharmaceuticals, LLC Medical Information at 1-866-516-4950 or to the FDA at www.fda.gov/medwatch or call 1-800-FDA-1088.

For additional safety information, please consult the TRIPTODUR full Prescribing Information

Please see full Prescribing Information for TRIPTODUR.